Heikki Mansikka

Heikki Mansikka is an experienced leader in clinical development and research, currently serving as Vice President of the Pain Therapy Area at Orion Corporation since May 2020, where responsibilities include overseeing research and early clinical development. Previously, Heikki held senior roles at Vertex Pharmaceuticals and Chromocell Corporation, focusing on pain therapeutics and neuropathic conditions. Academic involvement as an Adjunct Professor at the University of Turku manifests a commitment to education in Experimental Anaesthesiology. Heikki's earlier positions include Medical Director at AbbVie and Abbott, and Senior Director at Grunenthal, with a career foundation in early drug development at Pfizer Global R&D. Heikki Mansikka holds an MD in Medicine from the University of Helsinki and further training at The Johns Hopkins University School of Medicine.